Rating
Buy
Price target
$170
Previous
Implied upside
+32%

Freedom Broker analyst Almas Almaganbetov double upgraded Palantir (NASDAQ: PLTR) from Sell to Buy with a price target of $170.00.

“Palantir (PLTR) reported Q4 2025 results that materially exceeded management’s guidance and our estimate, driven by accelerating growth in the U.S. commercial and U.S. government segments.

The central catalyst was AIP in the U.S., which is accelerating sales momentum and rapidly converting pilots into large-scale contracts, while international performance continues to lag due to structural adoption and procurement barriers.

Operating execution also improved meaningfully, with gross and operating profitability expanding well ahead of market expectations.

Management’s upbeat Q1 2026 and full-year 2026 outlook, well above consensus, signals confidence that demand for AI infrastructure is durable and structural rather than cyclical.

We are increasing our 2026–2027 revenue forecasts and do not see new AI agents as a threat to Palantir’s long-term business model.

We maintain our $170 price target for PLTR and upgrade our rating from “Sell” to “Buy,” as the recent sharp pullback in the share price appears unjustified given continued hypergrowth and the underlying strength of the AIP platform.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.